Statistics
Publications
1
Citations
10
H-Index
1
Active since
2022
Affiliations
Radiation Oncology Associates(Current)
Sarah Ginn is an author at Radiation Oncology Associates specializing in targeted cancer therapy, oncogenic proliferation, and extracellular signal-regulated kinase signaling.
Publications per year
2022–2022
1
1
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma
Zachary Wolfe, Julie C. Friedland, Sarah Ginn et al. · Melanoma Research · 2022 · 10 citations · Full text
Medicine, Dermatology, Oncology +17
1–1 of 1